| 3/14/2024 | 293399809049 | N-NITROSO STAGLIPTIN- IMPURITY ( 60 MG ) | XXXXXXXXXX | 12 | UNIT | 3605 | INDIA | NA |
| 12/19/2023 | 293399809049 | N-NITROSO-L-PROLINE | XXXXXXXXXX | 1 | UNIT | 172 | Canada | NA |
| 12/19/2023 | 293399809049 | N-NITROSO-L-HYDROXYPROLINE | XXXXXXXXXX | 1 | UNIT | 233 | Canada | NA |
| 12/8/2023 | 293399809049 | APIGENINE (SYNONYMS: 4,5,7-TRYDROXYFLAVONE; APIGENOL; CI NATURAL YELLOW 1), N-NITROSO-N-METHYLUREA, CAFFEIC ACID, TANESPIMYCIN (SYNONYMS: 17-AAG; NSC 330507; CP 127374), PURMORPHAMINE, SCH772984 10 MM * 1 ML IN DMSO, HYPEROSIDE, | XXXXXXXXXX | 7 | UNIT | 701.89 | China | NA |
| 11/20/2023 | 293399809049 | N-NITROSO DIMETHYLAMINE D6 5 MG*HUMAN DRUG RAW MATERIAL SAMPLE* | XXXXXXXXXX | 1 | UNIT | 67.86 | INDIA | NA |
| 11/9/2023 | 293399809049 | DOTATATE 5MG"4-DIMETHYLAMINOPYRIDINE, 100 G"N,N-DIMETHYLGLYCINE HYDROCHLORIDE, 5 GCYCLO(ARG-GLY-ASP-D-PHE-CYS) 10MG"Y-27632 DIHYDROCHLORIDE, 10 MGN-NITROSO-N-METHYLUREA 1GR "KAINIC ACID, 50 MGATRACTYLOSIDE A 10MGCLODRONIC ACID DISODIUM SALT 50MG | XXXXXXXXXX | 9 | ADET(UNIT) | 1552.95 | China | NA |
| 10/31/2023 | 293399809049 | HUMAN PHARMACEUTICAL RAW MATERIAL (N-NITROSO-FUROSEMIDE SODIUM SALT) 50 MG = 1 pc. | XXXXXXXXXX | 1 | UNIT | 416 | INDIA | NA |
| 8/1/2023 | 293399809049 | N-NITROSO VILDAGLIPTIN 20 MG (HUMAN PHARMACEUTICAL RAW MATERIAL SAMPLE) | XXXXXXXXXX | 0.02 | GRAM | 200 | INDIA | NA |
| 7/17/2023 | 293399809049 | SAFINAMIDE N-OXIDE, N-NITROSO SAFINAMIDE ACID, N-NITROSO SAFINAMIDE, VONOPRAZAN NITROSO IMPURITY (WILL BE USED FOR ANALYSIS IN THE HUMAN PHARMACEUTICAL INDUSTRY) | XXXXXXXXXX | 0.08 | GRAM | 8169.49 | INDIA | NA |
| 6/9/2023 | 293399809049 | N-NITROSODIMETHYLAMINE N-NITROSODIMETHYLAMINE-D6 N-NITROSO-N-METHYLANINE IS NOT IN THE SCOPE OF 2023/5 NOTIFICATION | XXXXXXXXXX | 0.23 | GRAM | 1081.5 | INDIA | NA |